Skip to main content
. 2013 Oct 14;69(2):137–149. doi: 10.1111/all.12276

Table 3.

Overview of current comparative oncology trials initiated by the Comparative Oncology Trials Consortium of the National Cancer Institute

Study No. Name Status
COTC001 Evaluation of RGD Targeted Delivery of Phage Expressing TNF-alpha to Tumor Bearing Dogs Closed trial
COTC003 Evaluation of the MTOR inhibitor Rapamycin in dogs with osteosarcoma Closed trial
COTC005 Evaluation of immunocytokine fusion protein in tumor-bearing dogs Closed trial
COTC006 Evaluation Cryobiopsy Instrumentation And Cellsave Blood Collections In Dogs With Lymphoma Closed trial
COTC007a A Pilot Study of Topotecan in Dogs with Lymphoma Closed trial
COTC007b Preclinical Comparison of Three Indenoisoquinolines Candidates in Tumor Bearing Dogs Open
COTC008 Evaluation of the mTOR inhibitor Rapamycin in Dogs with Metastatic Osteosarcoma Closed trial
COTC010 Evaluation of two immunocytokine fusion proteins in tumor bearing dogs Closed trial
COTC013 Evaluation of Orally Administered mTOR inhibitor Rapamycin in Tumor Bearing Dogs Closed trial
COTC016 A Pilot Study to Assess Feasibility of Tissue Collections and Molecular Profiling for future Comparative Oncology Personalized Medicine Studies Closed trial
COTC018 Evaluation of a novel anticancer agent in tumor bearing dogs to define its pharmacokinetic profile and biological activity Open